Acumen Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Acumen Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $53.99 million for the year ending 2025.

  • Acumen Pharmaceuticals, Inc. showed an increase of +51.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Acumen Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Acumen Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 724.0%.
  • Historical annual values: Fiscal year 2025: $53.99 million | Fiscal year 2024: $35.63 million | Fiscal year 2023: $66.89 million | Fiscal year 2022: $130.10 million | Fiscal year 2021: $122.16 million | Fiscal year 2020: $43.78 million | Fiscal year 2019: $6.55 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: